22 biotech companies that will likely get bought as M&A heats up this summer

Hello,

Welcome to Insider Healthcare. I'm Lydia Ramsey Pflanzer, and today in healthcare news:

• 22 biotech companies that will likely get bought;
• Why the technology used to develop Pfizer's and Moderna's shots could help us treat more diseases;
• The next big public health threat is drug-resistant fungi.

If you're new to this newsletter, sign up here. Comments, tips? Email me at lramsey@insider.com or tweet @lydiaramsey125. Let's get to it...

---

A research scientist working at Arrowhead Pharmaceuticals

Arrowhead

Top biotech analysts say M&A is set to heat up this summer. Here are the 22 drug companies that are likely to get bought.

• Drug industry M&A has been slow in the first half of 2021, thanks to regulatory concerns and a stock market lull.
• Analysts at Jefferies say that the field is primed for new deals.
• Drug companies have more than $500 billion to spend. Companies like Vertex have said they're shopping.

See the full list>>

---

Dame Valerie Adams Receives Covid-19 Vaccination

Dave Rowland/Getty Images

Experts explain why the mRNA tech that revolutionized COVID-19 vaccines could be the answer to incurable diseases, heart attacks, and even snake bites: 'The possibilities are endless'

• The tech in Moderna's and Pfizer's COVID-19 vaccines could mend any protein in the body, experts say.
• The vaccines use a piece of genetic code, called mRNA, to tell cells what to produce.
• In the future, mRNA could help treat heart attacks, malaria, even deadly snake bites, six leading experts told Insider.

Get the full story>>

---

Scientific illustration of Candida auris.

Kateryna Kon/Getty Image

Deadly fungi are becoming drug-resistant, and it's the next big public health threat, experts say

• Some fungi have recently evolved drug resistance, to the concern of scientists.
• Fungi like C. auris infect the most vulnerable patients with compromised immune systems.
• COVID-19 treatments can leave hospitalized patients defenseless against superbugs.

Here's what's at stake>>

---

More stories we're reading:

• Galileo Health acquired a startup built by two college students. Here's how they did it. (MobiHealth News)
• Here are all the states offering cash prizes as an incentive to get the COVID-19 vaccine (Insider)
• What really happened with the recent Yankees COVID-19 outbreak (New York Magazine)
• The new CDC mask guidelines are confusing and could actually make the spread of COVID-19 worse, a group of leading physicians said (Insider)

---

- Lydia

Read the original article on Business Insider

from Business Insider https://ift.tt/3wxrVea